Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study

Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study

Background: JCOVDEN (Ad26.COV2.S), a viral-vector vaccine, was granted conditional marketing authorisation in the European Union for the prevention of COVID-19 in early 2021. We present JCOVDEN single-dose vaccine effectiveness (VE) estimates against COVID-19 hospitalisation. Methods: The id.DRIVE (...

Full description

Saved in:
Bibliographic Details
Main Authors: Chloé Wyndham-Thomas, E. Claire Newbern, Ainara Mira-Iglesias, Akshat Dwivedi, Alejandro Orrico Sánchez, Andrés Antón, Charlotte Martin, Giancarlo Icardi, Irma Casas, Kok Yew Ngew, Laura Drikite, Leonie de Munter, Gerrit Luit ten Kate, Nikki Vroom, Sebastian Baumgartner, Susana Otero-Romero, Xavier Holemans, Kaatje Bollaerts, Nicolas Praet
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Journal of Infection and Public Health
Subjects:
Ad26.COV2.S
SARS-CoV-2
Severe acute respiratory infection
Post-authorization
Study
Effectiveness
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034125000498
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1876034125000498

Similar Items